NCT00143871View on ClinicalTrials.gov

Study of Rituximab Plus High-Dose Chemotherapy Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

December 31, 2006

Study Completion Date

January 31, 2007

Conditions
Lymphoma, Non-Hodgkin's
Interventions
DRUG

Rituximab

Trial Locations (1)

48109

The University of Michigan, Ann Arbor

All Listed Sponsors
lead

University of Michigan Rogel Cancer Center

OTHER

NCT00143871 - Study of Rituximab Plus High-Dose Chemotherapy Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter